Global Human Microbiome Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2112290611 | Category: Medical Care | Pages: 114 | Format: PDF | Published Date: November 17,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Human Microbiome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Microbiome market size is estimated to be worth US$ 396 million in 2021 and is forecast to a readjusted size of USD 1483.8 million by 2028 with a CAGR of 20.8% during review period. Treatment accounting for  % of the Human Microbiome global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While Gastrointestinal Tract Human Micobiome segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Human Microbiome include Vedanta, Seres Therapeutics, Second Genome, Rebiotix, and ActoGeniX, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Human Microbiome market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Gastrointestinal Tract Human Micobiome
    Urogenital Tract Human Micobiome
    Others
Market segment by Application, can be divided into
    Treatment
    Diagnosis
Market segment by players, this report covers
    Vedanta
    Seres Therapeutics
    Second Genome
    Rebiotix
    ActoGeniX
    Enterome BioScience
    AvidBiotics
    4D Pharma Research Ltd
    Enterologics
    Metabogen
    Metabiomics
    Ritter Pharmaceuticals
    Osel
    Symberix
    Miomics
    Symbiotix Biotherapies
    MicroBiome Therapeutics LLC
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Human Microbiome product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Human Microbiome, with revenue, gross margin and global market share of Human Microbiome from 2019 to 2022.
Chapter 3, the Human Microbiome competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Human Microbiome market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Human Microbiome research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Human Microbiome
    1.2 Classification of Human Microbiome by Type
        1.2.1 Overview: Global Human Microbiome Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Human Microbiome Revenue Market Share by Type in 2021
        1.2.3 Gastrointestinal Tract Human Micobiome
        1.2.4 Urogenital Tract Human Micobiome
        1.2.5 Others
    1.3 Global Human Microbiome Market by Application
        1.3.1 Overview: Global Human Microbiome Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Treatment
        1.3.3 Diagnosis
    1.4 Global Human Microbiome Market Size & Forecast
    1.5 Global Human Microbiome Market Size and Forecast by Region
        1.5.1 Global Human Microbiome Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Human Microbiome Market Size by Region, (2017-2022)
        1.5.3 North America Human Microbiome Market Size and Prospect (2017-2028)
        1.5.4 Europe Human Microbiome Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Human Microbiome Market Size and Prospect (2017-2028)
        1.5.6 South America Human Microbiome Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Human Microbiome Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Human Microbiome Market Drivers
        1.6.2 Human Microbiome Market Restraints
        1.6.3 Human Microbiome Trends Analysis
2 Company Profiles
    2.1 Vedanta
        2.1.1 Vedanta Details
        2.1.2 Vedanta Major Business
        2.1.3 Vedanta Human Microbiome Product and Solutions
        2.1.4 Vedanta Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Vedanta Recent Developments and Future Plans
    2.2 Seres Therapeutics
        2.2.1 Seres Therapeutics Details
        2.2.2 Seres Therapeutics Major Business
        2.2.3 Seres Therapeutics Human Microbiome Product and Solutions
        2.2.4 Seres Therapeutics Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Seres Therapeutics Recent Developments and Future Plans
    2.3 Second Genome
        2.3.1 Second Genome Details
        2.3.2 Second Genome Major Business
        2.3.3 Second Genome Human Microbiome Product and Solutions
        2.3.4 Second Genome Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Second Genome Recent Developments and Future Plans
    2.4 Rebiotix
        2.4.1 Rebiotix Details
        2.4.2 Rebiotix Major Business
        2.4.3 Rebiotix Human Microbiome Product and Solutions
        2.4.4 Rebiotix Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Rebiotix Recent Developments and Future Plans
    2.5 ActoGeniX
        2.5.1 ActoGeniX Details
        2.5.2 ActoGeniX Major Business
        2.5.3 ActoGeniX Human Microbiome Product and Solutions
        2.5.4 ActoGeniX Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 ActoGeniX Recent Developments and Future Plans
    2.6 Enterome BioScience
        2.6.1 Enterome BioScience Details
        2.6.2 Enterome BioScience Major Business
        2.6.3 Enterome BioScience Human Microbiome Product and Solutions
        2.6.4 Enterome BioScience Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Enterome BioScience Recent Developments and Future Plans
    2.7 AvidBiotics
        2.7.1 AvidBiotics Details
        2.7.2 AvidBiotics Major Business
        2.7.3 AvidBiotics Human Microbiome Product and Solutions
        2.7.4 AvidBiotics Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 AvidBiotics Recent Developments and Future Plans
    2.8 4D Pharma Research Ltd
        2.8.1 4D Pharma Research Ltd Details
        2.8.2 4D Pharma Research Ltd Major Business
        2.8.3 4D Pharma Research Ltd Human Microbiome Product and Solutions
        2.8.4 4D Pharma Research Ltd Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 4D Pharma Research Ltd Recent Developments and Future Plans
    2.9 Enterologics
        2.9.1 Enterologics Details
        2.9.2 Enterologics Major Business
        2.9.3 Enterologics Human Microbiome Product and Solutions
        2.9.4 Enterologics Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Enterologics Recent Developments and Future Plans
    2.10 Metabogen 
        2.10.1 Metabogen Details
        2.10.2 Metabogen Major Business
        2.10.3 Metabogen Human Microbiome Product and Solutions
        2.10.4 Metabogen Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Metabogen Recent Developments and Future Plans
    2.11 Metabiomics
        2.11.1 Metabiomics Details
        2.11.2 Metabiomics Major Business
        2.11.3 Metabiomics Human Microbiome Product and Solutions
        2.11.4 Metabiomics Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Metabiomics Recent Developments and Future Plans
    2.12 Ritter Pharmaceuticals
        2.12.1 Ritter Pharmaceuticals Details
        2.12.2 Ritter Pharmaceuticals Major Business
        2.12.3 Ritter Pharmaceuticals Human Microbiome Product and Solutions
        2.12.4 Ritter Pharmaceuticals Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Ritter Pharmaceuticals Recent Developments and Future Plans
    2.13 Osel
        2.13.1 Osel Details
        2.13.2 Osel Major Business
        2.13.3 Osel Human Microbiome Product and Solutions
        2.13.4 Osel Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Osel Recent Developments and Future Plans
    2.14 Symberix
        2.14.1 Symberix Details
        2.14.2 Symberix Major Business
        2.14.3 Symberix Human Microbiome Product and Solutions
        2.14.4 Symberix Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Symberix Recent Developments and Future Plans
    2.15 Miomics
        2.15.1 Miomics Details
        2.15.2 Miomics Major Business
        2.15.3 Miomics Human Microbiome Product and Solutions
        2.15.4 Miomics Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Miomics Recent Developments and Future Plans
    2.16 Symbiotix Biotherapies
        2.16.1 Symbiotix Biotherapies Details
        2.16.2 Symbiotix Biotherapies Major Business
        2.16.3 Symbiotix Biotherapies Human Microbiome Product and Solutions
        2.16.4 Symbiotix Biotherapies Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Symbiotix Biotherapies Recent Developments and Future Plans
    2.17 MicroBiome Therapeutics LLC
        2.17.1 MicroBiome Therapeutics LLC Details
        2.17.2 MicroBiome Therapeutics LLC Major Business
        2.17.3 MicroBiome Therapeutics LLC Human Microbiome Product and Solutions
        2.17.4 MicroBiome Therapeutics LLC Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 MicroBiome Therapeutics LLC Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Human Microbiome Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Human Microbiome Players Market Share in 2021
        3.2.2 Top 10 Human Microbiome Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Human Microbiome Players Head Office, Products and Services Provided
    3.4 Human Microbiome Mergers & Acquisitions
    3.5 Human Microbiome New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Human Microbiome Revenue and Market Share by Type (2017-2022)
    4.2 Global Human Microbiome Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Human Microbiome Revenue Market Share by Application (2017-2022)
    5.2 Global Human Microbiome Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Human Microbiome Revenue by Type (2017-2028)
    6.2 North America Human Microbiome Revenue by Application (2017-2028)
    6.3 North America Human Microbiome Market Size by Country
        6.3.1 North America Human Microbiome Revenue by Country (2017-2028)
        6.3.2 United States Human Microbiome Market Size and Forecast (2017-2028)
        6.3.3 Canada Human Microbiome Market Size and Forecast (2017-2028)
        6.3.4 Mexico Human Microbiome Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Human Microbiome Revenue by Type (2017-2028)
    7.2 Europe Human Microbiome Revenue by Application (2017-2028)
    7.3 Europe Human Microbiome Market Size by Country
        7.3.1 Europe Human Microbiome Revenue by Country (2017-2028)
        7.3.2 Germany Human Microbiome Market Size and Forecast (2017-2028)
        7.3.3 France Human Microbiome Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Human Microbiome Market Size and Forecast (2017-2028)
        7.3.5 Russia Human Microbiome Market Size and Forecast (2017-2028)
        7.3.6 Italy Human Microbiome Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Human Microbiome Revenue by Type (2017-2028)
    8.2 Asia-Pacific Human Microbiome Revenue by Application (2017-2028)
    8.3 Asia-Pacific Human Microbiome Market Size by Region
        8.3.1 Asia-Pacific Human Microbiome Revenue by Region (2017-2028)
        8.3.2 China Human Microbiome Market Size and Forecast (2017-2028)
        8.3.3 Japan Human Microbiome Market Size and Forecast (2017-2028)
        8.3.4 South Korea Human Microbiome Market Size and Forecast (2017-2028)
        8.3.5 India Human Microbiome Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Human Microbiome Market Size and Forecast (2017-2028)
        8.3.7 Australia Human Microbiome Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Human Microbiome Revenue by Type (2017-2028)
    9.2 South America Human Microbiome Revenue by Application (2017-2028)
    9.3 South America Human Microbiome Market Size by Country
        9.3.1 South America Human Microbiome Revenue by Country (2017-2028)
        9.3.2 Brazil Human Microbiome Market Size and Forecast (2017-2028)
        9.3.3 Argentina Human Microbiome Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Human Microbiome Revenue by Type (2017-2028)
    10.2 Middle East & Africa Human Microbiome Revenue by Application (2017-2028)
    10.3 Middle East & Africa Human Microbiome Market Size by Country
        10.3.1 Middle East & Africa Human Microbiome Revenue by Country (2017-2028)
        10.3.2 Turkey Human Microbiome Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Human Microbiome Market Size and Forecast (2017-2028)
        10.3.4 UAE Human Microbiome Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Human Microbiome Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?